Full Text View
Tabular View
No Study Results Posted
Related Studies
The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia
This study has been completed.
Study NCT00247637   Information provided by National Institute of Mental Health (NIMH)
First Received: October 31, 2005   Last Updated: October 20, 2008   History of Changes

October 31, 2005
October 20, 2008
May 2003
September 2008   (final data collection date for primary outcome measure)
 
 
Complete list of historical versions of study NCT00247637 on ClinicalTrials.gov Archive Site
 
 
 
The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia
The Genetics of Endophenotypes and Schizophrenia

This is a study of the genetic basis of brain dysfunction in people with schizophrenia.

Schizophrenia is a disabling disorder that is associated with specific inheritable neurobiologic deficits. These deficits can cause problems with memory, visual attention, information processing, and other aspects of daily living. Understanding the genetic components of these deficits in people with schizophrenia and their unaffected family members may help uncover the neurobiological basis, risk factors, and heritability of the disease. In addition, the information may serve to create more effective treatments and possibly a cure for the disease. This study will serve to provide information about the genetic basis of known inherited neurobiological deficits in people with schizophrenia. In turn, this may guide further studies on the genetics of schizophrenia.

Participants will attend 2 study visits, each of which will last approximately 4 hours. The first will include blood tests and diagnostic interviews of participating families to evaluate the presence of schizophrenic symptoms. The second study visit will entail four neurocognitive and neurophysiological tests. Participants will first have a pre-pulse inhibition test, which uses electrodes to measure eye blinking. Electrodes will also be placed on participants' head, ears, and around their eyes to measure brain waves. Next, participants will undergo an oculomotor test, during which they will wear glasses fitted with sensors that record eye movement. Participants will then be asked to repeat a list of words, letters, and numbers read by a researcher. Last, participants will undergo a computerized performance test requiring them to watch the computer screen and click a mouse whenever they see a number between 0 and 9. Each study visit will take approximately 4 hours.

 
Observational
Prospective
Schizophrenia
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
1680
September 2008
September 2008   (final data collection date for primary outcome measure)

Inclusion Criteria for Participating Families:

  • Families with at least one member who has schizophrenia

Exclusion Criteria:

  • N/A
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00247637
 
R01 MH65571, R01 MH65707, R01 MH65578, R01 MH65588, R01 MH65554, R01 MH65562, DNBBS 7G-GRR
National Institute of Mental Health (NIMH)
 
Study Director: David Braff, MD University of California, San Diego
National Institute of Mental Health (NIMH)
October 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP